EXACT Sciences Corporation Cash Flow-to-Debt Ratio
EXACT Sciences Corporation cash flow-to-debt ratio. EXACT Sciences Corporation (EXAS) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of $151.69 Million could theoretically repay 0% of its total liabilities ($3.46 Billion) in one year. Check EXAS operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of EXACT Sciences Corporation (1999–2025)
Cash flow-to-debt ratio of EXACT Sciences Corporation from 1999 to 2025. Historical debt coverage capacity for EXACT Sciences Corporation across 27 annual periods. Check EXAS cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
EXACT Sciences Corporation Cash Flow-to-Debt Ratio by Year (1999–2025)
EXACT Sciences Corporation cash flow-to-debt ratio by year from 1999 to 2025. Year-by-year debt coverage analysis for EXACT Sciences Corporation. For the full cash flow conversion analysis, see EXAS operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | $491.44 Million | $3.46 Billion | ▲ +137.9% |
| 2024 | 0.06x | $210.54 Million | $3.53 Billion | ▲ +27.2% |
| 2023 | 0.05x | $156.12 Million | $3.33 Billion | ▲ +166.8% |
| 2022 | -0.07x | $-223.56 Million | $3.18 Billion | ▼ -126.5% |
| 2021 | -0.03x | $-102.24 Million | $3.30 Billion | ▼ -161.1% |
| 2020 | 0.05x | $136.48 Million | $2.69 Billion | ▲ +155.3% |
| 2019 | -0.09x | $-111.66 Million | $1.22 Billion | ▼ -11.5% |
| 2018 | -0.08x | $-69.33 Million | $843.08 Million | ▲ +91.0% |
| 2017 | -0.92x | $-71.72 Million | $78.14 Million | ▲ +70.5% |
| 2016 | -3.12x | $-130.07 Million | $41.74 Million | ▲ +13.0% |
| 2015 | -3.58x | $-134.02 Million | $37.44 Million | ▼ -0.2% |
| 2014 | -3.57x | $-80.91 Million | $22.64 Million | ▼ -2.9% |
| 2013 | -3.47x | $-39.30 Million | $11.31 Million | ▼ -6.4% |
| 2012 | -3.26x | $-44.16 Million | $13.52 Million | ▼ -57.9% |
| 2011 | -2.07x | $-27.82 Million | $13.46 Million | ▼ -157.1% |
| 2010 | -0.80x | $-13.48 Million | $16.76 Million | ▼ -25.2% |
| 2009 | -0.64x | $-12.64 Million | $19.68 Million | ▲ +32.3% |
| 2008 | -0.95x | $-7.90 Million | $8.33 Million | ▲ +10.1% |
| 2007 | -1.06x | $-8.77 Million | $8.31 Million | ▲ +22.6% |
| 2006 | -1.36x | $-12.15 Million | $8.91 Million | ▼ -12.9% |
| 2005 | -1.21x | $-15.98 Million | $13.22 Million | ▼ -3.5% |
| 2004 | -1.17x | $-21.17 Million | $18.13 Million | ▼ -89.1% |
| 2003 | -0.62x | $-13.87 Million | $22.45 Million | ▲ +39.2% |
| 2002 | -1.02x | $-11.92 Million | $11.74 Million | ▲ +73.5% |
| 2001 | -3.83x | $-15.84 Million | $4.13 Million | ▲ +34.9% |
| 2000 | -5.88x | $-7.99 Million | $1.36 Million | ▲ +56.1% |
| 1999 | -13.40x | $-4.61 Million | $343.89K | — |